Fibroblast Senescence as a Therapeutic Target of Myocardial Fibrosis beyond Spironolactone?

Gianluigi Condorelli; Gloria Saccani Jotti; Christina Pagiatakis

doi:10.1016/j.jacc.2016.02.048

Fibroblast Senescence as a Therapeutic Target of Myocardial Fibrosis beyond Spironolactone?

Gianluigi Condorelli, Gloria Saccani Jotti, Christina Pagiatakis

Istituto Clinico Humanitas

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	2029-2031
Number of pages	3
Journal	Journal of the American College of Cardiology
Volume	67
Issue number	17
DOIs	https://doi.org/10.1016/j.jacc.2016.02.048
Publication status	Published - May 3 2016

Keywords

aging
fibroblast
gene expression
heart failure
tumor suppressor genes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Cite this

Condorelli, G., Jotti, G. S., & Pagiatakis, C. (2016). Fibroblast Senescence as a Therapeutic Target of Myocardial Fibrosis beyond Spironolactone? Journal of the American College of Cardiology, 67(17), 2029-2031. https://doi.org/10.1016/j.jacc.2016.02.048

@article{e542c11894154a76a564ee08307c25b0,

title = "Fibroblast Senescence as a Therapeutic Target of Myocardial Fibrosis beyond Spironolactone?",

keywords = "aging, fibroblast, gene expression, heart failure, tumor suppressor genes",

author = "Gianluigi Condorelli and Jotti, {Gloria Saccani} and Christina Pagiatakis",

year = "2016",

month = may

day = "3",

doi = "10.1016/j.jacc.2016.02.048",

language = "English",

volume = "67",

pages = "2029--2031",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",